Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
Spratlin, J. L., Cohen, R. B., Eadens, M., Gore, L., Camidge, D. R., Diab, S., Leong, S., O'Bryant, C., Chow, L. Q.M., Serkova, N. J., Meropol, N. J., Lewis, N. L., Chiorean, E. G., Fox, F., YoussoufiVolume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2009.23.7537
Date:
February, 2010
File:
PDF, 193 KB
english, 2010